Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Scientific Contributions

Importance of the Renin System for Determining Blood Pressure Fall With Acute Salt Restriction in Hypertensive and Normotensive Whites

Feng J. He, Nirmala D. Markandu, Graham A. MacGregor
Download PDF
https://doi.org/10.1161/01.HYP.38.3.321
Hypertension. 2001;38:321-325
Originally published September 1, 2001
Feng J. He
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nirmala D. Markandu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham A. MacGregor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Abstract

Hypertensive (n=93) and normotensive (n=39) white individuals were given a high sodium intake of ≈350 mmol/d for 5 days followed by a low sodium intake of 10 to 20 mmol/d for 5 days. With this acute and large reduction in salt intake, no significant change was seen in blood pressure in the normotensive individuals, but blood pressure decreased in the hypertensive individuals. Compared with normotensive subjects, hypertensive patients had a 7/7-mm Hg greater fall in blood pressure (P<0.05 for systolic and P<0.01 for diastolic, adjusted for age), with similar changes in urinary sodium excretion. From the high-salt to low-salt diet, plasma renin activity rose from 0.90 to 5.99 ng · mL−1 · h−1 in normotensives, whereas in hypertensives it rose from 0.73 to only 3.14 ng · mL−1 · h−1 (P<0.05 between hypertensives and normotensives). Plasma aldosterone rose by 1396 pmol/L in normotensive subjects and by 511 pmol/L in hypertensive patients (P<0.05). Significant inverse correlations were obtained for all subjects between the fall in blood pressure from the high-salt to low-salt diet and the rise in plasma renin activity and aldosterone that occurred in addition to the absolute level on the low-salt diet. These results demonstrate that the larger fall in blood pressure with an acute reduction in salt intake in hypertensives compared with normotensives is, at least in part, due to a less-responsive renin-angiotensin-aldosterone system in the hypertensive patients.

  • renin-angiotensin system
  • blood pressure
  • sodium
  • diet, sodium-restricted
  • hypertension, essential
  • normotension

Substantial evidence suggests that an acute and large reduction in salt intake causes a significant fall in blood pressure (BP) in patients with essential hypertension,1–3 whereas a smaller or no change in BP appears to occur in normotensive subjects.4,5 The mechanism for this difference is not fully understood. Some studies have suggested that the fall in BP with a reduction in salt intake is related to blunting of the renin response that occurs in many patients with essential hypertension.6–10 This effect was shown directly with the use of an angiotensin II antagonist, saralasin.7 We previously showed the importance of the response of the renin-angiotensin-aldosterone system in determining the different BP responses to salt restriction between black (of African origin) and white hypertensive patients.11 In white subjects (93 with essential hypertension and 39 with normal BP), we studied the difference in BP response to an acute and large reduction in salt intake to elucidate further the mechanism of BP fall. All participants were studied on their usual diet and then placed on a high-salt diet for 5 days followed by a low-salt diet for 5 days. BP, plasma renin activity, and aldosterone levels were measured.

Methods

Ninety-three patients with essential hypertension (systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg) and 39 subjects with normal BP (systolic BP <140 mm Hg and diastolic BP <90 mm Hg) were studied. Patients with high BP either had not received previous treatment or had not received treatment for ≥3 months before the study. The study group included 46 male and 47 female hypertensives (mean age, 50 years; range, 19 to 70 years) and 25 male and 14 female normotensives (mean age, 28 years; range, 19 to 62 years). All subjects gave informed consent. The study was approved by the local hospital ethics committee.

Subjects were studied on a high sodium intake of ≈350 mmol/d for 5 days followed by a low sodium intake of 10 to 20 mmol/d for 5 days. High sodium intake was achieved by supplementing the normal diet with 20 slow sodium tablets (200 mmol/d). A low-sodium diet was provided by the metabolic unit kitchen. Potassium intake was not altered for either diet.

BP was measured in each subject in the same arm by nurses who used semiautomatic ultrasound sphygmomanometers (Arteriosonde) with attached recorders. Therefore, measurements were free from observer bias. Supine BPs were the mean of 5 readings taken at 1- to 2-minute intervals. Two 24-hour urine samples were collected during the last 2 days of each dietary period for measurement of sodium, potassium, and creatinine. Blood was also taken at the end of each diet period for measurement of electrolytes, creatinine, plasma renin activity,12 and aldosterone.13

Results are reported as mean±SEM. Changes in continuous variables within each group were analyzed by paired t tests. Comparisons between hypertensives and normotensives at baseline (on the normal diet) were made with unpaired t tests for continuous variables and χ2 test for categorical data. Because of the significant difference between hypertensives and normotensives in age, we used a multiple linear regression model for comparison between the 2 groups in changes in BP and other continuous variables while adjusting for age. All statistical analyses were performed by use of Statistical Package for Social Science (SPSS) software.

Results

Baseline Characteristics

Table 1 shows results obtained on the final day of the usual salt intake (before alteration of salt intake) for hypertensive and normotensive subjects. Hypertensives were older and slightly heavier than normotensives. Average BP for subjects on the normal diet was 170/106±2.4/1.2 mm Hg and 116/74±1.9/1.2 mm Hg in the hypertensive and normotensive individuals, respectively. Plasma renin activity was significantly lower in the hypertensives than normotensives. No significant difference was seen between hypertensives and normotensives in levels of plasma sodium, potassium, and creatinine, and urinary sodium, potassium, creatinine, and volume on the usual diet.

View this table:
  • View inline
  • View popup
Table 1.

Patient Characteristics, BP, and Laboratory Data on the Normal Diet

High Salt to Low Salt Intake

Figure 1 shows distribution of change in mean arterial pressure with acute salt restriction in normotensive (Figure 1A) and hypertensive individuals (Figure 1B). Table 2 summarizes average changes in BP, body weight, and other laboratory measurements from the high-salt to low-salt diet in hypertensives and normotensives as well as age-adjusted difference between hypertensives and normotensives in change in BP and other measurements. For a similar reduction in 24-hour urinary sodium excretion, the hypertensives had a greater fall in BP and smaller rise in plasma renin activity and aldosterone compared with normotensives. The reduction in body weight with acute salt restriction was smaller in hypertensives than in normotensives. No significant differences were seen between hypertensives and normotensives in changes in supine pulse rate, plasma sodium, potassium, creatinine, urinary sodium, potassium, creatinine, and volume.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Distribution of change in mean arterial pressure with acute salt restriction in normotensive (A) and hypertensive (B) individuals.

View this table:
  • View inline
  • View popup
Table 2.

BP and Laboratory Data After 5 Days on Different Salt Intake

Correlations Between BP Response and Other Variables

Taking all subjects together, the fall in mean arterial pressure with the low-salt diet was significantly correlated with age (r=0.47, P<0.001). A significant inverse correlation also occurred between the fall in mean arterial pressure with salt restriction and (1) plasma renin activity (log-transformed values) on the low-salt diet (r=−0.35, P<0.001) (Figure 2); (2) rise in plasma renin activity from the high-salt to the low-salt diet (r=−0.33, P<0.001); (3) plasma aldosterone on low-salt diet (r=−0.42, P<0.001); and (4) rise in plasma aldosterone (r=−0.42, P<0.001). Correlation analyses also were performed in hypertensives and normotensives separately. Subgroup analyses showed that most significant inverse correlations between changes in BP and plasma renin activity or aldosterone were present in hypertensives alone, but no significant correlations were found in the normotensives alone.

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Relationship between fall in mean arterial pressure from high-salt to low-salt diet and plasma renin activity on low-salt diet.

To further investigate the quantitative relationship between the change in BP and the renin system, we performed a multiple linear regression analysis. R2 was 0.21 when the change in mean arterial pressure was entered as a dependent variable and the changes in plasma renin activity and aldosterone levels and absolute levels on the low-salt diet were entered as independent variables. R2 changed to 0.29 when the status (hypertensive=1, normortensive=0) was added to the independent variables. R2 changed little (0.31) when changes in body weight, urinary sodium, and potassium excretion were added to the independent variables. These results also demonstrate the importance of the renin-angiotensin system in determining the fall in BP with acute salt restriction.

Comparisons Between Hypertensives and Normotensives in Changes in BP and Plasma Renin Activity in 34 Subjects Matched for Age and Sex

Age is an important confounding factor in the present study due to the fact that hypertensive patients were significantly older than normotensive subjects, and the finding that age was significantly correlated with the fall in BP with the low-salt diet. To exclude further potential bias due to the age difference, we matched a subgroup of normotensives and hypertensives by age and gender. A total of 34 subjects were matched (17 normotensives and 17 hypertensives). Average age was 35±3 and 36±3 years for the normotensives and hypertensives, respectively. Each group had 10 men and 7 women.

Figure 3 shows change in systolic BP, plasma renin activity, and urinary sodium excretion from high-salt to low-salt diet in age- and sex-matched normotensive and hypertensive individuals. With a similar reduction in salt intake, the hypertensive patients had a 9/6-mm Hg greater fall in BP compared with that of the normotensive subjects (P<0.05 for both systolic and diastolic BP). Plasma renin activity rose from 0.77±0.20 to 6.12±0.91 ng · mL−1 · h−1 in normotensive subjects, whereas in hypertensive patients it only rose from 0.89±0.17 to 3.94±0.53 ng · mL−1 · h−1 (P<0.05 hypertensives versus normotensives). Results for the other measurements in these matched subjects also were similar to those observed in the larger number of subjects.

Figure3
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 3. Changes in systolic BP, plasma renin activity, and urinary sodium excretion from the high-salt to low-salt diet in 34 age- and sex-matched normotensive and hypertensive individuals. *P<0.01, †P<0.001 low-salt vs high-salt diet; ‡P<0.05 hypertensives vs normotensives in change in systolic BP and plasma renin activity.

In the age- and sex-matched individuals, a significant correlation was seen between the fall in mean arterial pressure and the change in plasma renin activity with salt restriction (r=−0.41, P<0.05). However, the fall in BP was not significantly associated with change in plasma aldosterone or with absolute levels of plasma renin activity or aldosterone on low-salt diet.

Discussion

Several studies have investigated responses of BP to acute manipulation of sodium and volume balance in humans. However, in some of these studies, a nonphysiological protocol was followed to achieve sodium depletion, including administration of furosemide.14–16 Although the study by Weinberger et al10 showed congruence of 2 different approaches for the assessment of BP response to salt, controversy still exists.17 Among the studies that used a dietary approach, most were performed in hypertensive patients and some in normotensive individuals, and few were done simultaneously. The present study demonstrates that with a similar acute reduction in salt intake, hypertensive patients have a greater fall in BP with smaller rises in plasma renin activity and aldosterone. The fall in BP with salt restriction was significantly related to the plasma renin activity and aldosterone on the low-salt diet and to the rise in plasma renin activity and aldosterone ongoing from the high-salt to the low-salt diet. These results suggest that the greater fall in BP with salt restriction in hypertensive patients is, at least in part, due to a decreased responsiveness of the renin-angiotensin-aldosterone system in hypertensives.

Our findings of different responses of BP and renin system to an alteration of dietary salt intake between hypertensives and normotensives are in agreement with the findings by Weinberger et al,15 who studied 378 normal volunteers and 198 patients with essential hypertension by use of rapid sodium and volume expansion (saline infusion) and contraction maneuvers (low-salt diet and furosemide administration). In their study, after acute sodium and volume depletion, hypertensive patients had a larger fall in mean arterial pressure compared with normotensives. They also found that subjects who had greater BP response to sodium depletion (ie, more sodium sensitive) had lower plasma renin activity at baseline and less rise in plasma renin activity after sodium and volume depletion. Overlack et al5 investigated BP responses to 1 week of low sodium (20 mmol/d) and high sodium (300 mmol/d) intake in 163 normotensive whites. With the alteration of sodium intake, no significant change was seen in average BP. However, individual BP response was heterogeneous, which was related to plasma renin activity at baseline and during low-salt and high-salt diets. More recently, Krekels et al8 studied interrelationships among cumulative sodium loss, renin activation, and BP changes during moderate sodium restriction (55 mmol/d) in 55 patients with untreated essential hypertension. They found that the change in BP with the alteration of salt intake was also related to the response of the renin system but not to the change in sodium balance. Our results support this conclusion, given that the weight loss with salt reduction was not related to the fall in BP.

When comparing 2 different tests for assessment of BP responses to sodium in the same individuals, Weinberger et al10 demonstrated that increases in plasma renin activity with sodium and water depletion induced by the low-salt diet and furosemide in the first study predicted (correlated with, P<0.001) the BP response to the low-salt diet in the second study, which was conducted 3 months later. Our previous study7 with the use of the angiotensin II antagonist saralasin showed that the fall in BP with saralasin was inversely correlated with the fall in BP with salt restriction. These results indicated that subjects who had the biggest fall in BP with salt restriction had the least fall in BP with saralasin when salt was restricted and that those subjects who had little change in BP with salt restriction had a bigger fall in BP with saralasin when salt was restricted. This relationship provides direct evidence that the fall in BP with salt restriction is, at least in part, mediated by reactivity of the renin-angiotensin system.

In the present study, the major components of the renin-angiotensin-aldosterone system and their responsiveness explained 21% of the variability of BP responses to acute salt restriction. The combination of the components and responsiveness of the renin-angiotensin-aldosterone system with patient status (hypertensives versus normotensives) and changes in body weight, urinary sodium, and potassium excretion explained 29% of the variability of BP responses to acute salt restriction. Therefore, a large percentage of the variability of BP responses to acute salt restriction is due to other mechanisms that merit further studies. The recent study by Morris et al18 suggests that potassium intake has a significant effect on BP response to a dietary salt loading. In the present study, potassium intake was not altered. However, with acute salt restriction there was a small reduction in 24-hour urinary potassium excretion (4.6 mmol in normotensives, P=0.236; and 8.8 mmol in hypertensives, P<0.001). These small changes in urinary potassium excretion may have some confounding effects on the BP responses to salt restriction. However, they are unlikely to account for the difference between hypertensives and normotensives in BP responses to alteration of salt intake, given that neither the urinary potassium excretion nor plasma potassium was significantly different between hypertensives and normotensives either at baseline or from the high-salt to low-salt diet. Other studies have suggested that the sympathetic nervous system,19,20 the kallikrein-kinin system,21 the NO system,22 and many eicosanoids23 also may contribute to the BP responses to acute alteration of salt intake. How far these changes are integrated into the response of the renin-angiotensin system is not clear, although much evidence suggests a complex feedback system between activity of the sympathetic nervous system and activity of the renin-angiotensin-aldosterone system.

In conclusion, our results demonstrate that with an acute reduction in salt intake, hypertensive patients have a greater fall in BP compared with normotensive subjects. This greater fall in BP is, at least in part, due to decreased responsiveness of the renin-angiotensin-aldosterone system in hypertensives. Our findings reinforce the accumulating evidence that, at least in the short-term (5 days), changes in BP with a reduction in salt intake are, at least in part, modulated by reactivity of the renin-angiotensin-aldosterone system.

  • Received October 10, 2000.
  • Revision received January 15, 2001.
  • Accepted February 26, 2001.

References

  1. ↵
    MacGregor GA. Salt, blood pressure, the kidney, and other harmful effects. Nephrol Dial Transplant. . 1998; 13: 2471–2479.
    OpenUrlFREE Full Text
  2. ↵
    MacGregor GA, Markandu ND, Sagnella GA, Singer DRJ, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. . 1989; 2: 1244–1247.
    OpenUrlCrossRefPubMed
  3. ↵
    Culter JA, Follmann D, Allender PS. Randomised trials of sodium restriction: an overview. Am J Clin Nutr. . 1997; 65 (suppl): 643S–651S.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Parfrey PS, Markandu ND, Roulston JE, Jones BE, Jones JC, MacGregor GA. Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension. BMJ. . 1981; 283: 94–97.
  5. ↵
    Overlack A, Ruppert M, Kolloch R, Gobel B, Kraft K, Diehl J, Schmitt W, Stumpe KO. Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension. . 1993; 22: 331–338.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    MacGregor GA. The importance of the response of the renin-angiotensin system in determining blood pressure changes with sodium restriction. Br J Clin Pharmacol. . 1987; 23: 21s–26s.
  7. ↵
    Cappuccio FP, Markandu ND, Sagnella GA, MacGregor GA. Sodium restriction lowers high blood pressure through a decreased response of the renin system: direct evidence using saralasin. J Hypertens. . 1985; 3: 243–247.
    OpenUrlCrossRefPubMed
  8. ↵
    Krekels MME, Schaper NC, de Leeuw PW. Sensitivity of blood pressure and renin activation during sodium restriction. Hypertension. . 1997; 30: 1216–1222.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Krekels MME, van Es PN, Leunissen KML, De Leeuw PW. Sodium sensitivity of blood pressure in hypertensives is not related to sodium, but rather to renin. J Hum Hypertens. . 1996; 10 (suppl 3): S127–S130.
  10. ↵
    Weinberger MH, Stegner JE, Fineberg NS. A comparison of two tests for the assessment of blood pressure responses to sodium. Am J Hypertens. . 1993; 6: 179–184.
    OpenUrlPubMed
  11. ↵
    He FJ, Markandu ND, Sagnella GA, MacGregor GA. Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension. . 1998; 32: 820–824.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Roulston JE, MacGregor GA. Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage. Clin Chim Acta. . 1978; 88: 45–48.
    OpenUrlCrossRefPubMed
  13. ↵
    James VHT, Wilson GA. Determination of aldosterone in biological fluids. In: Reid Eed. Assay of Drugs and Other Trace Compounds in Biological Fluids. Methodological Developments in Biochemistry. Vol 5. New York, NY: Elsevier; 1976: 149–158.
  14. ↵
    Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. . 1996; 27: 481–490.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. . 1986; 8 (pt 2): II-127–II-134.
    OpenUrl
  16. ↵
    Luft FC, Grim CE, Fineberg N, Weinberger MC. Effect of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation. . 1979; 59: 643–650.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Sharma AM, Schorr U, Cetto C, Distler A. Dietary v intravenous salt loading for the assessment of salt sensitivity in normotensive men. Am J Hypertens. . 1994; 7: 1070–1075.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Morris RC, Jr Sebastian A, Forman A, Tanaka M, Schmidlin O. Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension. . 1999; 33: 18–23.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Campese VM, Romoff MS, Levitan J, Saglikes Y, Fredier R, Massry SG. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int. . 1982; 21: 371–378.
    OpenUrlCrossRefPubMed
  20. ↵
    Taddei S, Virdis A, Mattei P, Favilla S, Salvetti A. Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. Hypertension. . 1995; 25: 595–601.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Ferri C, Bellini C, Carlomagno A, Perrone A, Santucci A. Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney Int. . 1994; 46: 780–788.
    OpenUrlPubMed
  22. ↵
    Tolins JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensitivity to pressor effect of salt. Kidney Int. . 1994; 46: 230–236.
    OpenUrlCrossRefPubMed
  23. ↵
    Nasjletti A. The role of eicosanoids in angiotensin-dependent hypertension. Hypertension. . 1998; 31: 194–200.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
July 2001, Volume 38, Issue 3
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Importance of the Renin System for Determining Blood Pressure Fall With Acute Salt Restriction in Hypertensive and Normotensive Whites
    Feng J. He, Nirmala D. Markandu and Graham A. MacGregor
    Hypertension. 2001;38:321-325, originally published September 1, 2001
    https://doi.org/10.1161/01.HYP.38.3.321

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Importance of the Renin System for Determining Blood Pressure Fall With Acute Salt Restriction in Hypertensive and Normotensive Whites
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Importance of the Renin System for Determining Blood Pressure Fall With Acute Salt Restriction in Hypertensive and Normotensive Whites
    Feng J. He, Nirmala D. Markandu and Graham A. MacGregor
    Hypertension. 2001;38:321-325, originally published September 1, 2001
    https://doi.org/10.1161/01.HYP.38.3.321
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Basic, Translational, and Clinical Research
    • Clinical Studies

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured